Where to buy tirzepatide legally: a buyer's reality check

Last updated 2026-07-30

Is it legal to buy tirzepatide without a prescription?

No. Tirzepatide is a prescription-only drug in the United States under both its brand names, Zepbound (approved for chronic weight management) and Mounjaro (approved for type 2 diabetes). The FDA approved Zepbound in November 2023 and Mounjaro in May 2022 ^[1]. There is no legal over-the-counter version, no legal "research chemical" version for human use, and no legal way to buy it as a supplement. Any website selling tirzepatide vials, nasal sprays, or lozenges without requiring a prescription is operating outside the law, full stop. The FDA has specifically warned that products sold as tirzepatide "for research purposes" are frequently mislabeled, contaminated, or contain none of the actual peptide ^[2]. If a site doesn't ask a licensed clinician to review your health history before selling you an injectable peptide, that's the first red flag, not a convenience feature. The legal path always runs through a prescriber. That can be your primary care doctor, an endocrinologist, or a telehealth platform with licensed physicians or nurse practitioners on staff. What varies legally is not whether you need a prescription (you do) but where that prescription gets filled.

What are the actual legal ways to get tirzepatide?

There are three legitimate channels, and they're not interchangeable. Brand-name Zepbound or Mounjaro, filled at a retail or mail-order pharmacy. This is FDA-approved tirzepatide, manufactured by Eli Lilly, dispensed by a licensed pharmacy (CVS, Walgreens, Costco, Lilly's own LillyDirect pharmacy, or a mail-order plan pharmacy) against a valid prescription. This is the gold-standard route: known dose, known manufacturing, FDA oversight of the facility. Compounded tirzepatide from a state-licensed 503A pharmacy. Under section 503A of the Federal Food, Drug, and Cosmetic Act, a licensed pharmacist can compound a drug for an individual patient with a valid prescription, typically when the commercial product is on FDA's drug shortage list or isn't clinically appropriate as-is (a different strength, no BPA-free vial, etc.) ^[3]. 503A pharmacies are regulated primarily by state boards of pharmacy, not FDA directly. Compounded tirzepatide from a 503B outsourcing facility. These facilities register with FDA under section 503B and must follow current Good Manufacturing Practice (CGMP) rules, similar in spirit to drug manufacturers ^[4]. They can produce in bulk without patient-specific prescriptions in hand at the time of compounding, then supply prescribers or 503A pharmacies. FDA maintains a public list of registered 503B facilities ^[4]. All three routes require a prescription. None of them are a Facebook ad, an Instagram DM, or a site with no clinician review.

Is compounded tirzepatide legal, or only during a shortage?

This is the part that changed and confuses a lot of people. For most of 2023 and 2024, tirzepatide was on FDA's drug shortage list, which is what allowed 503A and 503B pharmacies to legally compound copies at scale, even for patients without an individualized medical necessity for compounding. FDA removed tirzepatide injection from the shortage list in December 2024, confirming Lilly's supply could meet demand ^[5]. After that, the legal room for mass compounding narrowed. Under FDA rules, once a drug is off the shortage list, 503A and 503B compounders generally can't produce a copy of an FDA-approved drug's active ingredient in essentially the same form unless there's a documented patient-specific need (allergy to an excipient, need for a different dose than what's commercially made, or similar) ^{[3] [4]}. Some compounders and telehealth companies have continued offering tirzepatide by compounding with added ingredients (like vitamin B12) or by asserting individualized need, and litigation and FDA enforcement activity around this has continued into 2025. The practical takeaway: compounded tirzepatide can still be legal in narrower circumstances, but the "anyone can get compounded tirzepatide cheap because of the shortage" era is largely over. If a compounding pharmacy can't articulate why your prescription needs a compounded version rather than Zepbound or Mounjaro, ask harder questions.

What's the difference between brand-name and compounded tirzepatide?

Brand-name Zepbound and Mounjaro are the exact molecule tested in Eli Lilly's SURMOUNT and SURPASS trial programs, manufactured under FDA-inspected conditions, with FDA batch oversight. Compounded tirzepatide is supposed to be the same active pharmaceutical ingredient, but it's produced by a pharmacy or outsourcing facility that is not required to prove bioequivalence to FDA the way a generic drug manufacturer would. That distinction matters because FDA has publicly flagged quality problems in some compounded tirzepatide products, including cases where compounders used tirzepatide salt forms (like tirzepatide acetate) that have never been FDA-evaluated for safety or efficacy in humans, versus the tirzepatide base used in Zepbound and Mounjaro ^[6]. | Feature | Brand (Zepbound/Mounjaro) | 503A/503B compounded |

How do I check if an online pharmacy is legitimate?

A few concrete checks, before you enter a credit card number anywhere. First, does the pharmacy require a prescription, or a licensed clinician's evaluation before dispensing, with no exceptions? Legitimate telehealth platforms have a real doctor or NP review your intake form and, often, a video or phone visit. If a site sells to you with just a credit card and no clinical review, that's disqualifying on its own. Second, look for state pharmacy licensure. NABP (National Association of Boards of Pharmacy) runs a Verified Internet Pharmacy Practice Sites (VIPPS) accreditation program, and you can search their tools to check if an online pharmacy is legitimate ^[7]. FDA also keeps a public warning-letter and safety-alert archive specifically covering unauthorized tirzepatide sellers ^[2]. Third, check whether the facility is a registered 503B outsourcer if it's compounding. FDA publishes the current list of registered outsourcing facilities ^[4]; if a company claims 503B status, it should be on that list, and you can verify it in under a minute. Fourth, be suspicious of prices that are too good relative to the market. Sub-$100/month tirzepatide, sold with no medical intake, from a site that only accepts crypto or wire transfer, is not a bargain. It's usually unregulated material of unknown purity, sometimes contaminated, sometimes containing none of the actual peptide ^[2].

What does tirzepatide actually cost through legal channels?

Costs vary a lot by insurance status and pharmacy, but here's the honest range. With commercial insurance covering Zepbound for an FDA-approved indication, copays can run as low as $25/month with Lilly's savings card program, subject to eligibility rules and coverage caps. Without insurance coverage, Lilly's own list price and LillyDirect self-pay pricing for Zepbound single-dose vials runs roughly $349 to $499 per month depending on dose, a price Lilly cut in 2024 specifically to compete with compounding pharmacies. Mounjaro list price without insurance is higher, generally in the $1,000+/month range through retail pharmacy channels, though manufacturer savings programs can lower this substantially for eligible patients. Compounded tirzepatide from legitimate 503A/503B pharmacies has historically run $150 to $400+ per month, again varying by dose and pharmacy overhead. But remember: since the December 2024 shortage resolution, the legal footing for broad compounding narrowed, so a very cheap compounded offer today deserves more scrutiny about why it's still being compounded at all ^[5]. Medicare does not cover GLP-1/GIP drugs for weight loss alone as of 2025, though it can cover Zepbound when prescribed for an FDA-approved comorbid indication like moderate-to-severe obstructive sleep apnea, per CMS guidance on covered self-injectable drugs; check current CMS and plan-specific rules before assuming coverage either way.

What red flags mean a tirzepatide seller is not legal or not safe?

No medical questionnaire, no clinician contact, ship-anywhere policy. Real prescribing requires a real clinical review, even if it's a short telehealth visit. Selling "research use only" tirzepatide, or tirzepatide peptides marketed for injection with disclaimers that it's "not for human consumption." This is a common workaround gray-market sellers use to dodge drug regulation, and FDA has specifically warned about it ^[2]. Vials with no clear labeling of concentration, no lot number, no compounding pharmacy name and state license number visible. Every legitimate compounded prescription should have this information. Prices dramatically below the compounded-pharmacy range ($150-$400/month), especially combined with crypto-only payment or no U.S. business address. Unsolicited marketing via social media DM or spam email offering tirzepatide, especially claiming to bypass the need for a prescription entirely. Legitimate telehealth companies advertise openly and route you to an actual medical intake, they don't cold-DM strangers.

Does insurance cover tirzepatide, and does that change where I should buy it?

If your insurance covers Zepbound or Mounjaro, the legal and financial answer converges: fill it at a licensed retail pharmacy using your prescription benefit. Coverage depends heavily on your specific plan, employer benefit design, and diagnosis. Many commercial plans cover Mounjaro for type 2 diabetes fairly consistently; coverage for Zepbound (weight management alone) is more inconsistent and sometimes requires prior authorization showing a BMI threshold or weight-related comorbidity. If you're uninsured or your plan excludes GLP-1 drugs for weight loss, the realistic legal options are Lilly's self-pay LillyDirect pricing for Zepbound, or a properly licensed compounding pharmacy if your prescriber determines you have a documented reason (dose customization, ingredient sensitivity) that justifies compounding rather than the FDA-approved product. Either way, the purchase decision should follow the prescription, not precede it. A legitimate provider will tell you honestly whether compounding is appropriate for your case, rather than defaulting to it because it's cheaper for the business.

What has FDA actually said about tirzepatide's safety profile?

This matters for the "where to buy" question because a drug with real risks needs real prescribing oversight, not a checkout cart. Zepbound and Mounjaro carry a boxed warning for risk of thyroid C-cell tumors, based on findings in rodent studies; they are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) ^[8]. Whether tirzepatide causes MTC in humans is unknown; the warning exists because of the animal signal. In the SURMOUNT-1 trial (NCT04184622), the most common adverse events were gastrointestinal: nausea, diarrhea, and vomiting, generally mild-to-moderate and more frequent during dose escalation ^[9]. Across the SURPASS program for type 2 diabetes (trials including NCT03954834 for SURPASS-1), similar GI effects were seen, along with a low but real signal for acute pancreatitis and gallbladder-related events (cholelithiasis, cholecystitis) tied to rapid weight loss and GLP-1 receptor agonism generally ^[10]. A prescriber who actually reviews your history can screen for personal or family MTC/MEN2 history, gallbladder disease, pancreatitis history, and pregnancy status, none of which a no-questions-asked online seller will ever ask about. That's the real argument for buying through a legal, prescription-based channel: it's not paperwork for its own sake, it's the mechanism that catches contraindications before they become a hospital visit.

How does a provider-reviewed route actually work?

In practice, a legal, provider-reviewed path looks like this: you complete a health intake covering weight history, current medications, thyroid and pancreas history, and any prior GLP-1 use. A licensed clinician (MD, DO, or NP depending on state rules) reviews it, sometimes via a video visit, and decides if tirzepatide is appropriate and at what starting dose. If approved, the prescription routes to a licensed pharmacy, brand-name or a properly licensed compounder, which fills and ships the medication with your name, the prescriber's name, and dosing instructions on the label. Tirz Rx's own approach is to point readers toward that provider-reviewed path rather than direct sales; the clinical review happens first, and the fulfilling pharmacy is named and licensed rather than anonymous. That's the structural difference between a legal purchase and a gray-market one: a named, licensed, accountable party at every step, more than a checkout page. If you're earlier in the decision process and want the evidence base before you get to the "where" question, it's worth reading through the trial results and real-world outcomes first: see our breakdowns on tirzepatide reviews, the tirzepatide results timeline, and whether tirzepatide is worth it for your situation before committing to a purchase channel.

Can I legally buy tirzepatide from Canada, Mexico, or another country and import it?

Generally, no, not for personal legal import in the way people assume. FDA policy allows very narrow personal importation exceptions (roughly a 90-day supply, for serious conditions with no domestic treatment, among other conditions), but tirzepatide has domestic FDA-approved options (Zepbound, Mounjaro), which undercuts the exception's usual justification ^[2]. Customs and Border Protection can and does seize injectable drugs shipped from unlicensed foreign pharmacies. Beyond the legal question, imported product from unverified foreign pharmacies carries the same quality-control uncertainty as domestic gray-market sellers: no guarantee of correct dose, sterility, or even correct active ingredient. If cost is the driver, the better move is comparing Lilly's own LillyDirect self-pay pricing, manufacturer savings cards, and licensed U.S. compounding options, not international gray-market shipping.

Frequently asked questions

Can you buy tirzepatide over the counter?

No. Tirzepatide is prescription-only in the U.S. under both brand names, Zepbound and Mounjaro. There is no legal over-the-counter, supplement, or non-prescription version. Any product sold without requiring a prescription or clinical review is being sold outside FDA regulation, regardless of how it's marketed.

Is compounded tirzepatide legal in 2025?

It can be, but only in narrower circumstances than before. FDA removed tirzepatide from its drug shortage list in December 2024, which restricts mass compounding to cases with documented patient-specific need, like an allergy or dosing requirement the commercial product can't meet. A pharmacy compounding it purely because it's cheaper is on shakier legal ground now.

What's the cheapest legal way to get tirzepatide?

For insured patients with coverage, a retail-pharmacy copay (sometimes as low as $25/month via Lilly's savings card) is cheapest. Uninsured, Lilly's LillyDirect self-pay Zepbound pricing runs roughly $349-$499/month depending on dose. Compounded options can run less, but verify the pharmacy's license and legal basis for compounding before choosing price alone.

How do I know if an online tirzepatide seller is legitimate?

Check for a required medical intake or clinician review before any sale, verifiable state pharmacy licensure (searchable via NABP), and, if compounded, confirmation the facility is on FDA's registered 503B outsourcing facility list. No prescription requirement, crypto-only payment, or vague sourcing claims are all disqualifying red flags.

Does Mounjaro or Zepbound work better, and does that affect where I buy it?

They're the same drug, tirzepatide, at the same doses; Mounjaro is FDA-approved for type 2 diabetes, Zepbound for chronic weight management. Your diagnosis, not a preference, determines which one your prescriber writes and which one insurance is more likely to cover, but the legal purchase channel (licensed pharmacy, valid prescription) is identical for both.

Can I get tirzepatide without seeing a doctor in person?

Yes. Legitimate telehealth platforms can legally prescribe tirzepatide after a clinician (MD, DO, or NP, depending on state law) reviews your intake and often conducts a video visit. What's required is a real clinical evaluation, not an in-person visit specifically. What's not legal is a purchase with zero clinical review at all.

Is it legal to import tirzepatide from Canada or Mexico for personal use?

Generally no. FDA's personal importation policy is narrow and typically doesn't apply when an FDA-approved domestic option (Zepbound, Mounjaro) already exists for the same use. Customs can seize shipments from unlicensed foreign pharmacies, and quality control on those products is unverified.

What's the difference between 503A and 503B compounding pharmacies?

503A pharmacies compound for individual patients with a specific prescription and are regulated mainly by state pharmacy boards. 503B outsourcing facilities register with FDA, follow CGMP manufacturing standards, and can produce larger batches, often supplying prescribers or 503A pharmacies directly. Both require a valid prescription to dispense tirzepatide to you.

What are the biggest safety risks I should ask my prescriber about?

Ask about personal or family history of medullary thyroid carcinoma or MEN 2 (both are contraindications per the boxed warning), history of pancreatitis or gallbladder disease, and current GI conditions, since nausea, vomiting, and diarrhea are the most common side effects reported in the SURMOUNT and SURPASS trials.

Does insurance ever cover tirzepatide for weight loss?

Sometimes, but coverage for Zepbound specifically for weight management is inconsistent across plans and often requires prior authorization based on BMI or weight-related health conditions. Coverage for Mounjaro in type 2 diabetes tends to be more consistent. Check your specific formulary; Medicare does not cover it for weight loss alone as of 2025.

What should I look for on a compounded tirzepatide vial's label?

A legitimate compounded vial should list the pharmacy's name, state license number, the prescriber's name, exact concentration and volume, lot number, and beyond-use date. Missing any of this is a sign the product didn't come through a properly licensed, accountable compounding channel.

Why did compounded tirzepatide get harder to find legally after 2024?

FDA declared the tirzepatide shortage resolved in December 2024, confirming Eli Lilly's manufacturing could meet demand. That removed the shortage-based legal justification that had allowed widespread compounding, narrowing legal compounding to cases with documented individual medical necessity rather than general availability.

Sources

1. FDA, Zepbound approval announcement: FDA approved Zepbound (tirzepatide) for chronic weight management in November 2023
2. FDA, Medications Containing Semaglutide/Tirzepatide Marketed for Weight Loss: FDA warning about mislabeled, contaminated, or fake compounded GLP-1/GIP products sold online
3. FDA, Human Drug Compounding (Section 503A): 503A pharmacies may compound patient-specific prescriptions under FD&C Act section 503A
4. FDA, Registered Outsourcing Facilities Under Section 503B: 503B outsourcing facilities must register with FDA and follow CGMP; FDA maintains a public list
5. FDA Drug Shortages Database, Tirzepatide Injection: FDA resolved the tirzepatide injection shortage in December 2024
6. FDA, Compounded Tirzepatide Products Safety Communication: FDA flagged use of non-approved tirzepatide salt forms (e.g., tirzepatide acetate) in some compounded products
7. National Association of Boards of Pharmacy, Verified Internet Pharmacy Practice Sites: NABP's VIPPS program verifies legitimate online pharmacies
8. FDA, Zepbound Prescribing Information (Boxed Warning): Zepbound carries a boxed warning for thyroid C-cell tumor risk and is contraindicated in personal/family history of MTC or MEN 2
9. ClinicalTrials.gov, SURMOUNT-1 (NCT04184622): SURMOUNT-1 trial evaluated tirzepatide for chronic weight management; GI adverse events were most common
10. ClinicalTrials.gov, SURPASS-1 (NCT03954834): SURPASS-1 trial evaluated tirzepatide in type 2 diabetes as part of the SURPASS program